These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Neurobiology and pharmacotherapy of social phobia]. Aouizerate B; Martin-Guehl C; Tignol J Encephale; 2004; 30(4):301-13. PubMed ID: 15538306 [TBL] [Abstract][Full Text] [Related]
3. Treatment of social phobia with antidepressants. Schneier FR J Clin Psychiatry; 2001; 62 Suppl 1():43-8; discussion 49. PubMed ID: 11206033 [TBL] [Abstract][Full Text] [Related]
4. Practical approaches to the treatment of social phobia. J Clin Psychiatry; 1994 Aug; 55(8):367-74. PubMed ID: 7915277 [No Abstract] [Full Text] [Related]
5. Social phobia: a pharmacologic treatment overview. Jefferson JW J Clin Psychiatry; 1995; 56 Suppl 5():18-24. PubMed ID: 7782272 [TBL] [Abstract][Full Text] [Related]
6. New uses for antidepressants: social phobia. Keck PE; McElroy SL J Clin Psychiatry; 1997; 58 Suppl 14():32-6; discussion 37-8. PubMed ID: 9418744 [TBL] [Abstract][Full Text] [Related]
7. Pharmacotherapy of social phobia. A controlled study with moclobemide and phenelzine. Versiani M; Nardi AE; Mundim FD; Alves AB; Liebowitz MR; Amrein R Br J Psychiatry; 1992 Sep; 161():353-60. PubMed ID: 1393304 [TBL] [Abstract][Full Text] [Related]
8. The pharmacotherapy of social phobia. Pollack MH; Gould RA Int Clin Psychopharmacol; 1996 Jun; 11 Suppl 3():71-5. PubMed ID: 8923113 [TBL] [Abstract][Full Text] [Related]
9. WCA recommendations for the long-term treatment of social phobia. Van Ameringen M; Allgulander C; Bandelow B; Greist JH; Hollander E; Montgomery SA; Nutt DJ; Okasha A; Pollack MH; Stein DJ; Swinson RP; CNS Spectr; 2003 Aug; 8(8 Suppl 1):40-52. PubMed ID: 14767397 [TBL] [Abstract][Full Text] [Related]
10. Medication treatments for panic disorder and social phobia. Stein MB Depress Anxiety; 1998; 7(3):134-8. PubMed ID: 9656095 [TBL] [Abstract][Full Text] [Related]
11. Treatment of social phobia with drugs other than benzodiazepines. Liebowitz MR; Schneier FR; Hollander E; Welkowitz LA; Saoud JB; Feerick J; Campeas R; Fallon BA; Street L; Gitow A J Clin Psychiatry; 1991 Nov; 52 Suppl():10-5. PubMed ID: 1757452 [TBL] [Abstract][Full Text] [Related]
12. Social phobia: diagnosis, severity and implications for treatment. Montgomery SA Eur Arch Psychiatry Clin Neurosci; 1999; 249 Suppl 1():S1-6. PubMed ID: 10361959 [TBL] [Abstract][Full Text] [Related]
13. Moclobemide in social phobia: a controlled dose-response trial. Noyes R; Moroz G; Davidson JR; Liebowitz MR; Davidson A; Siegel J; Bell J; Cain JW; Curlik SM; Kent TA; Lydiard RB; Mallinger AG; Pollack MH; Rapaport M; Rasmussen SA; Hedges D; Schweizer E; Uhlenhuth EH J Clin Psychopharmacol; 1997 Aug; 17(4):247-54. PubMed ID: 9241002 [TBL] [Abstract][Full Text] [Related]
14. Moclobemide in the treatment of social phobia. Nutt D; Montgomery SA Int Clin Psychopharmacol; 1996 Jun; 11 Suppl 3():77-82. PubMed ID: 8923114 [TBL] [Abstract][Full Text] [Related]
15. Moclobemide. An update of its pharmacological properties and therapeutic use. Fulton B; Benfield P Drugs; 1996 Sep; 52(3):450-74. PubMed ID: 8875133 [TBL] [Abstract][Full Text] [Related]
16. Reversible and selective inhibitors of monoamine oxidase A in mental and other disorders. Priest RG; Gimbrett R; Roberts M; Steinert J Acta Psychiatr Scand Suppl; 1995; 386():40-3. PubMed ID: 7717094 [TBL] [Abstract][Full Text] [Related]
17. Meta-analysis of the reversible inhibitors of monoamine oxidase type A moclobemide and brofaromine for the treatment of depression. Lotufo-Neto F; Trivedi M; Thase ME Neuropsychopharmacology; 1999 Mar; 20(3):226-47. PubMed ID: 10063483 [TBL] [Abstract][Full Text] [Related]
18. Recent developments in the psychopharmacology of social phobia. Den Boer JA; van Vliet IM; Westenberg HG Eur Arch Psychiatry Clin Neurosci; 1995; 244(6):309-16. PubMed ID: 7772614 [TBL] [Abstract][Full Text] [Related]